The coronavirus outbreak COVID-19, which has been listed as a pandemic by the World Health Organization, affects especially vulnerable people and those with previous illnesses. While there is still no evidence on how coronavirus COVID-19 disease affects people with Down syndrome, we know that, in general, people with Down syndrome may have some underlying factors … Read more
The Alzheimer-Down Unit (Catalan Down Syndrome Foundation and Hospital de la Santa Creu i Sant Pau) participates in an international registry of people with Down syndrome affected by the coronavirus COVID-19 infection. This registry is powered by the Scientific Society for the Study of Trisomy 21 (T21 Research Society). The objective is to know the … Read more
The Alzheimer – Down Unit, that comprises researchers from the Sant Pau Memory Unit of the Neurology Service at Hospital de la Santa Creu i Sant Pau and the Fundació Catalana Síndrome de Down, has published the results of a study of biomarkers in blood and cerebrospinal fluid of adults with Down syndrome in the … Read more
In collaboration with Fundació Catalana Síndrome de Down Life expectancy of people with Down syndrome has exponentially increased in recent decades and currently exceeds 65 years. This great success has led to the emergence of new medical problems associated with aging in this population, especially Alzheimer’s disease. Down syndrome is considered a genetically determined form … Read more
Sant Pau Initiative on Neurodegeneration 1. What is the SPIN cohort? The main objective of the SPIN cohort (Sant Pau Initiative on Neurodegeneration) is to widen our knowledge of neurodegenerative diseases such as Alzheimer’s disease, Lewy body dementia and frontotemporal lobe degeneration, through the study of biochemical and neuroimaging markers (also known as biomarkers). This … Read more